Clinical Implications and Future Perspectives of Circulating Tumor Cells and Biomarkers in Clinical Outcomes of Colorectal Cancer-Reference-Cited by-同舟云学术

Clinical Implications and Future Perspectives of Circulating Tumor Cells and Biomarkers in Clinical Outcomes of Colorectal Cancer

Published:2016-08 Issue:4 Volume:9 Page:340-347
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Huang Ming-Yii,Tsai Hsiang-Lin,Huang Joh-Jong,Wang Jaw-Yuan

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference82 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. Cost-effectiveness of screening for colorectal cancer in the general population;Frazier;JAMA,2000

3. Diagnostic challenges in detection of colorectal cancer;Jumba;East Afr Med J,2008

4. Stool screening for colorectal cancer: evolution from occult blood to molecular markers;Ahlquist;Clin Chim Acta,2002

5. Periodic health examination, 1994 update: 2. Screening strategies for colorectal cancer. Canadian Task Force on the Periodic Health Examination;Solomon;CMAJ,1994

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring Salivary Biomarkers for Tumor Diagnosis: A Narrative Review;Cureus;2024-07-30

2. Diagnostic performances of methylated septin9 gene, CEA, CA19-9 and platelet-to-lymphocyte ratio in colorectal cancer;BMC Cancer;2024-07-27

3. Clinical value of circulating tumour cells in evaluating the efficacy of continuous hepatic arterial infusion among colorectal cancer patients;Journal of Chemotherapy;2024-05-06

4. Salivary Protein Biomarkers for Diagnosis of Oral Squamous Cell Carcinoma;Current Cancer Drug Targets;2024-01

5. The emergence of RAS mutations in patients with RAS wild-type mCRC receiving cetuximab as first-line treatment: a noninterventional, uncontrolled multicenter study;British Journal of Cancer;2023-07-24